Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Veriteque is a private U.S. diagnostics and safety-testing company that manufactures single-use presumptive field test kits for narcotics, explosives, gunshot residue, and related harmful substances. Its products are marketed under the SwabTek brand for institutional and professional users and the Verifique brand for consumer-oriented at-home drug testing. The company emphasizes dry, paper-based chemistry tests designed to be simple, rapid, and safer to use than traditional liquid-reagent field tests. Veriteque appears to be commercially active, with products sold directly and through distribution partnerships, including agreements covering U.S. and point-of-care diagnostics channels. Although healthcare-adjacent rather than a therapeutics developer, the company operates within diagnostics/testing relevant to public health, workplace safety, education, and law enforcement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veriteque.